By integrating network pharmacology and weighted gene co-expression network analysis, critical gene modules linked to tumor phenotypes, EMT-related adverse prognosis, and elevated MTFR2 expression were identified, pinpointing the core target gene. This evidence concerns the gene MTFR2 and neoplasm.